根据该协议,Catalent将向TFF提供其扩大规模的专业知识和制造能力,作为其首选的开发和制造合作伙伴,Catalent将能够向其客户提供TFF技术,这有可能增加...查看全文
美港电讯APP2020-09-24 21:21
TFF制药(TFFP.O):在实验中,发现含亮氨酸的瑞德西韦干粉制剂能更持久地从肺释放到到血浆,公司正与吉利德科学(GILD.O)就此研究结果进行讨论。$TFF Pharmaceuticals(TFFP)$ $吉利德科学(GILD)$ (来自美港电讯APP)查看全文
chuminhua2020-08-14 10:55
8月13日,TFF Pharmaceuticals,Inc.$TFF Pharmaceuticals(TFFP)$ 是一家临床阶段的生物制药公司,专注于根据其专利的薄膜冷冻(TFF)技术平台开发和商业化创新药物产品,宣布已与UNION therapeutics签订了一项全球独家许可协议,将其TFF技术与氯硝柳胺(niclosamide)联合使用。根据协议条款,UNI...查看全文
$TFF Pharmaceuticals(TFFP)$ 内部交易: 2020-04-03,Director,Fletcher Aaron G.L. ,买入,16748普通股, $3.97
$TFF Pharmaceuticals(TFFP)$ 内部交易: 2020-04-02,Director,Fletcher Aaron G.L. ,买入,500普通股, $3.75
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-008707 Size: 7 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-20-007544 Act: 34 Size: 3 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-20-007502 Act: 34 Size: 92 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-004227 Size: 5 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-20-002686 Size: 4 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-20-022641 Act: 34 Size: 34 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, item 5.02 Accession Number: 0001213900-20-002287 Act: 34 Size: 18 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-19-026904 Size: 5 KB 网页链接